- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Authors
Latest:
Prevention and Management of COVID-19 in Hemodialysis CentersThis article gives recommendations for individual hemodialysis centers worldwide to ensure the safety and effectiveness of patients receiving maintenance hemodialysis based on the experience of such a patient with coronavirus disease 2019 (COVID-19) in the Sichuan province of China.
Latest:
The Role of Real-World Data in Advancing Value-Based Cancer Care: CK Wang, MDCK Wang, MD, chief medical officer of COTA, discusses how real-world data help identify disparities and gaps in cancer care.
Latest:
Impact of Expanded Carrier Screening on Health Care UtilizationThis study shows little evidence of harms or increased health care utilization for people receiving negative (normal) results of expanded carrier screening through genome sequencing.
Latest:
Gaps in the Coordination of Care for Older Adults With or at Risk for Cardiovascular DiseaseOlder adults with cardiovascular disease (CVD) or CVD risk factors report that gaps in communication among their providers are common and hazardous.
Latest:
Using Electronic Health Records and Claims Data to Identify High-risk Patients Likely to Benefit From Palliative CareDeep learning algorithms could improve palliative care by predicting mortality from electronic health records and claims data.
Latest:
Pricing and Insurance Networks in Outpatient Surgery MarketsThis article examines how prices, insurer payments, and patient payments for outpatient surgeries differ by site of care and network status.
Latest:
High-Intensity Home-Based Rehabilitation in a Medicare Accountable Care OrganizationHigh-intensity home-based rehabilitation (HIHR) may substitute for facility-based postacute rehabilitation. Patients in HIHR had better functional outcomes at lower costs than patients in facility-based care.
Latest:
Cost Sharing for Oral Lenvatinib Among Commercially Insured PatientsAmong a cohort of insured patients with cancer, the median total monthly cost of oral lenvatinib was $17,253, and 75% of patients paid $100 or less out of pocket per month for the drug.
Latest:
Trends in Medicare Advantage Participation Among Commercial InsurersAn increasing number of people with employer-sponsored insurance are covered by an insurer that offers Medicare Advantage in the state.
Latest:
Assessing Opportunities to Advance Quality Measures in Adult ObesityObesity is a serious chronic disease and risk factor for a broad range of outcomes. This study identifies opportunities for improving quality in obesity care.
Latest:
Demographic Disparities in Video Visit Telemetry: Understanding Telemedicine UtilizationA stratified demographics analysis of video visit telemetry data reveals that age older than 65 years and African American/Black race are associated with higher video visit failure rates, whereas language, sex, and ethnicity are not.
Latest:
Development and Validation of the COVID-19 Hospitalized Patient Deterioration IndexThe authors developed and validated an accurate, well-calibrated, easy-to-implement COVID-19 hospitalized patient deterioration index to identify patients at high or low risk of clinical deterioration.
Latest:
Linvoseltamab Approval Expands Access, Increases Competition in BCMA Bispecifics Space: Sundar Jagannath, MBBSFollowing the FDA approval of linvoseltamab (Lynozyfic; Regeneron) for heavily pretreated multiple myeloma, Sundar Jagannath, MBBS, highlights its potential for earlier use, increased accessibility, and greater competition in the B-cell maturation antigen (BCMA) bispecific antibody space.
Latest:
The Impact of Outliers on Available Resources in a Teaching Hospital in ColombiaThis letter describes the experience of long-stay patients and provides a perspective of the need for more studies on outliers’ impact on health care.
Latest:
Community Health Workers’ Critical Role in Trust Building Between the Medical System and Communities of ColorThe authors interrogate elements of routine medical practice in New York City to argue for reforms of hospital culture through relational trust-building capabilities of community health workers.
Latest:
Treatment Modification After Initiating Second-Line Medication for Type 2 DiabetesAmong adults with type 2 diabetes who started noninsulin second-line therapy, most modified treatment within 1 year. Discontinuation was by far the most common modification.
Latest:
Improving Pain Clinic Outcomes With Preappointment Surveys: Data-Driven Policy ChangeImplementing a policy change to require preappointment surveys before scheduling initial clinic evaluations can improve wait-list times and show rates.
Latest:
Potential Health Literacy Resources for Health Plans: A Narrative ReviewSeveral evidence-based health literacy resources may be beneficial in health plan settings to improve organizational health literacy, personal health literacy, and health equity.
Latest:
Predicting Mortality Risk Using the PREVENT Equation Across Diverse Racial GroupsThis study validates the Predicting Risk of CVD Events (PREVENT) score across diverse racial and ethnic populations, highlighting its effectiveness in predicting cardiovascular risk and mortality, regardless of race or ethnicity.
Latest:
Cost Sharing for Oral Lenvatinib Among Commercially Insured PatientsAmong a cohort of insured patients with cancer, the median total monthly cost of oral lenvatinib was $17,253, and 75% of patients paid $100 or less out of pocket per month for the drug.
Latest:
Integrating Research, Health Care, and Community at Scale to Address the Population Health QuestionThe authors discuss the need to repair a house divided among research, health care, and the multisector health community.
Latest:
Economics of a Health System’s Direct-to-Consumer Telemedicine for Its EmployeesA direct-to-consumer telemedicine service resulted in lower per-episode unit costs for care within 7 days and only marginally increased the use of services overall.
Latest:
Having Someone Who Cares: Patient Perspectives of Care Management ProgramsThis article presents a single-organization qualitative case description of the perspectives of patients with high-need, high-cost illnesses who participated in care management programs.
Latest:
Navigating the Alzheimer Disease Blood Test RevolutionA new FDA-approved blood test for Alzheimer disease could transform diagnosis and treatment accessibility, according to this conversation with Howard Fillit, MD, and Anthony “Nino” Sireci, MD, MSc.
Latest:
Changes in Marketplace Competition and Television Advertising by InsurersThis study provides the first evidence on how Marketplace insurers are altering their marketing in response to changes in competitive pressure over time.
